These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


426 related items for PubMed ID: 17460146

  • 1. Crim1KST264/KST264 mice implicate Crim1 in the regulation of vascular endothelial growth factor-A activity during glomerular vascular development.
    Wilkinson L, Gilbert T, Kinna G, Ruta LA, Pennisi D, Kett M, Little MH.
    J Am Soc Nephrol; 2007 Jun; 18(6):1697-708. PubMed ID: 17460146
    [Abstract] [Full Text] [Related]

  • 2. Crim1KST264/KST264 mice display a disruption of the Crim1 gene resulting in perinatal lethality with defects in multiple organ systems.
    Pennisi DJ, Wilkinson L, Kolle G, Sohaskey ML, Gillinder K, Piper MJ, McAvoy JW, Lovicu FJ, Little MH.
    Dev Dyn; 2007 Feb; 236(2):502-11. PubMed ID: 17106887
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival.
    Eremina V, Cui S, Gerber H, Ferrara N, Haigh J, Nagy A, Ema M, Rossant J, Jothy S, Miner JH, Quaggin SE.
    J Am Soc Nephrol; 2006 Mar; 17(3):724-35. PubMed ID: 16436493
    [Abstract] [Full Text] [Related]

  • 4. Functional symbiosis between endothelium and epithelial cells in glomeruli.
    Hirschberg R, Wang S, Mitu GM.
    Cell Tissue Res; 2008 Feb; 331(2):485-93. PubMed ID: 17999087
    [Abstract] [Full Text] [Related]

  • 5. Crim1 has an essential role in glycogen trophoblast cell and sinusoidal-trophoblast giant cell development in the placenta.
    Pennisi DJ, Kinna G, Chiu HS, Simmons DG, Wilkinson L, Little MH.
    Placenta; 2012 Mar; 33(3):175-82. PubMed ID: 22225908
    [Abstract] [Full Text] [Related]

  • 6. Loss of renal microvascular integrity in postnatal Crim1 hypomorphic transgenic mice.
    Wilkinson L, Gilbert T, Sipos A, Toma I, Pennisi DJ, Peti-Peterdi J, Little MH.
    Kidney Int; 2009 Dec; 76(11):1161-71. PubMed ID: 19776720
    [Abstract] [Full Text] [Related]

  • 7. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular endothelia.
    Davis B, Dei Cas A, Long DA, White KE, Hayward A, Ku CH, Woolf AS, Bilous R, Viberti G, Gnudi L.
    J Am Soc Nephrol; 2007 Aug; 18(8):2320-9. PubMed ID: 17625119
    [Abstract] [Full Text] [Related]

  • 8. Kidney development and gene expression in the HIF2alpha knockout mouse.
    Steenhard BM, Freeburg PB, Isom K, Stroganova L, Borza DB, Hudson BG, St John PL, Zelenchuk A, Abrahamson DR.
    Dev Dyn; 2007 Apr; 236(4):1115-25. PubMed ID: 17342756
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.
    Kitamoto Y, Tokunaga H, Tomita K.
    J Clin Invest; 1997 May 15; 99(10):2351-7. PubMed ID: 9153276
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy.
    Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN.
    Nephrol Dial Transplant; 2005 Jul 15; 20(7):1320-8. PubMed ID: 15840669
    [Abstract] [Full Text] [Related]

  • 11. Distinct sites of renal fibrosis in Crim1 mutant mice arise from multiple cellular origins.
    Phua YL, Martel N, Pennisi DJ, Little MH, Wilkinson L.
    J Pathol; 2013 Apr 15; 229(5):685-96. PubMed ID: 23224993
    [Abstract] [Full Text] [Related]

  • 12. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in beta3-integrin-deficient mice.
    Reynolds AR, Reynolds LE, Nagel TE, Lively JC, Robinson SD, Hicklin DJ, Bodary SC, Hodivala-Dilke KM.
    Cancer Res; 2004 Dec 01; 64(23):8643-50. PubMed ID: 15574772
    [Abstract] [Full Text] [Related]

  • 13. Association between congenital defects in papillary outgrowth and functional obstruction in Crim1 mutant mice.
    Wilkinson L, Kurniawan ND, Phua YL, Nguyen MJ, Li J, Galloway GJ, Hashitani H, Lang RJ, Little MH.
    J Pathol; 2012 Aug 01; 227(4):499-510. PubMed ID: 22488641
    [Abstract] [Full Text] [Related]

  • 14. VEGF-dependent induction of CD62E on endothelial cells mediates glioma tropism of adult haematopoietic progenitor cells.
    Tabatabai G, Herrmann C, von Kürthy G, Mittelbronn M, Grau S, Frank B, Möhle R, Weller M, Wick W.
    Brain; 2008 Oct 01; 131(Pt 10):2579-95. PubMed ID: 18689869
    [Abstract] [Full Text] [Related]

  • 15. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth.
    Liang XB, Ma LJ, Naito T, Wang Y, Madaio M, Zent R, Pozzi A, Fogo AB.
    J Am Soc Nephrol; 2006 Jul 01; 17(7):1886-95. PubMed ID: 16790514
    [Abstract] [Full Text] [Related]

  • 16. Knockdown of zebrafish crim1 results in a bent tail phenotype with defects in somite and vascular development.
    Kinna G, Kolle G, Carter A, Key B, Lieschke GJ, Perkins A, Little MH.
    Mech Dev; 2006 Apr 01; 123(4):277-87. PubMed ID: 16524703
    [Abstract] [Full Text] [Related]

  • 17. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
    Ryu J, Lee CW, Hong KH, Shin JA, Lim SH, Park CS, Shim J, Nam KB, Choi KJ, Kim YH, Han KH.
    Cardiovasc Res; 2008 May 01; 78(2):333-40. PubMed ID: 18006432
    [Abstract] [Full Text] [Related]

  • 18. VEGF expression and receptor activation in the choroid during development and in the adult.
    Saint-Geniez M, Maldonado AE, D'Amore PA.
    Invest Ophthalmol Vis Sci; 2006 Jul 01; 47(7):3135-42. PubMed ID: 16799060
    [Abstract] [Full Text] [Related]

  • 19. Sam68-like mammalian protein 2, identified by digital differential display as expressed by podocytes, is induced in proteinuria and involved in splice site selection of vascular endothelial growth factor.
    Cohen CD, Doran PP, Blattner SM, Merkle M, Wang GQ, Schmid H, Mathieson PW, Saleem MA, Henger A, Rastaldi MP, Kretzler M.
    J Am Soc Nephrol; 2005 Jul 01; 16(7):1958-65. PubMed ID: 15901763
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G, Xu P, Mutsaers AJ, Dumont DJ, Kerbel RS.
    Cancer Res; 2008 Jan 15; 68(2):521-9. PubMed ID: 18199548
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.